Akoya Biosciences, Inc.: operating_income
| Value | {"amount": -39298000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Akoya Biosciences, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:31:34.229190+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d9af93f9-ec8f-4438-9ef7-36a2ad8d889c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-003581Retrieved: 2026-08-19T17:31:34.229190+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001711933/operating-income/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d9af93f9-ec8f-4438-9ef7-36a2ad8d889c
History
- no predecessors — first report